HEADLINES: Tiaji turns to Grey to promote anti-obesity drug

<p>China's state-owned Tiaji Group has signed on Grey Worldwide: </p><p>Shanghai to boost the brand profile for its anti-obesity drug, Qumei, </p><p>which it launched in July 2000. </p><p><BR><BR> </p><p>Grey's appointment marks the first time that the 21-year-old </p><p>pharmaceutical group, which is listed on the Shanghai stock exchange and </p><p>last year hit annual sales of Rmb 2 billion (USdollars 242 million), is </p><p>using a multinational 4A's agency to work on its brands. </p><p><BR><BR> </p>

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features